• Sunday, Jan 17, 2021
  • Last Update : 06:37 pm

Liver drug treatment hope for dengue fever after Dhaka research

  • Published at 08:36 pm November 25th, 2020
File photo of dengue patients at a hospital in Dhaka Mehedi Hasan/Dhaka Tribune

Some 390 million people contract dengue virus globally each year

In a major breakthrough, researchers in Bangladesh have found that an existing medicine called eltrombopag — used to treat chronic immune thrombocytopenia or chronic hepatitis C infection — could be repurposed to create the first drug treatment for the deadly dengue fever.

Some 390 million people contract dengue virus globally each year. While most patients experience fever or a mild form of the disease, a small percentage goes on to develop the potentially fatal dengue haemorrhagic fever (DHF), wherein blood leaks from ruptured blood vessels leading to dengue shock syndrome (DSS).

In its experiment, a team of 12 from Dhaka University and Dhaka Medical College administered a small dose (25 mg) of eltrombopag to 101 dengue patients and saw the success of the drug, a release issued by Dhaka University's Department of Biochemistry and Molecular Biology said.

Dr Sajib Chakraborty, associate professor of the department, who is also one of the researchers, said: “One of the symptoms of dengue is low blood platelets. But there is a medicine called eltrombopag that increases blood platelets. But it has never been used in dengue. We started research on how it can work in the dengue treatment,”

Novartis, an international pharmaceutical giant, developed the drug in 2008, which was approved by the US Food and Drug Administration (FDA) in 2014. Eltrombopag is mainly used when the platelets are low in liver disease, apart from other ailments.

Also Read- Dengue threat looms large

Dr Chakraborty said, “Since the number of platelets in dengue patients decreases, we have speculated that this medicine may work to increase the platelet count in patients. However, we were not 100% sure. Then we started experimenting with this.”

“We have seen good results in our research,” he said, adding: “About 92% of the dengue patients — who took eltrombopag — had their platelet counts returned to normal in eight days. Of those who did not take this medicine, only 55% recovered. As a result, most of the patients are recovering after taking this medication.”

About the side effects of the medicine, Dr. Chakraborty said: “We have also seen whether there is any side effect of the eltrombopag ‍as many platelets can cause damage if they increase. Many times blood can clot. But in the case of patients, [this medicine] did not get anything like that. Only 3% of patients had reported some side effects, such as diarrhoea.”

The researchers said it was a second-phase test. However, in order to fully confirm the success of this medicine on dengue, it is necessary to conduct human testing on thousands of people in multiple countries in the third phase.

“The drug has not yet been approved by the World Health Organization (WHO). But if it succeeds in testing on a larger scale like ours, then surely it will be included in the guidelines for the treatment of dengue,” he said.

The study, conducted from October 2019 to February 2020, has been published in The Lancet Journal of Clinical Medicine. The study was funded by a pharmaceutical company called Incepta Pharmaceuticals of Bangladesh.

Facebook 54
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail